Prevention of Influenza and Other Wintertime Respiratory Viruses Among Healthcare Professionals in Israel
HCP
1 other identifier
observational
2,400
1 country
2
Brief Summary
The purpose of the study on the Prevention of Influenza and Other Wintertime Respiratory Viruses among Healthcare Professionals in Israel Effectiveness of Influenza Vaccine in Preventing Influenza Virus Infection, Missed Work, and Patient Exposure: A Prospective Cohort Study of Healthcare Personnel (to be called the Healthcare Personnel or HCP study throughout this Data Security Plan) is to investigate vaccine effectiveness and respiratory illness among healthcare personnel (HCP). This will help to better understand the factors that influence influenza vaccination choice, individual vaccine response, and whether or not the influenza vaccine helps to prevent influenza in HCP.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2016
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 27, 2016
CompletedStudy Start
First participant enrolled
September 28, 2016
CompletedFirst Posted
Study publicly available on registry
November 6, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2019
CompletedJuly 31, 2024
November 1, 2017
2.8 years
July 27, 2016
July 30, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Frequency of acute respiratory illness among healthcare personnel receiving influenza vaccine
3 years
Proportion of work days missed associated with self-reported acute respiratory illness
3 years
Secondary Outcomes (2)
Frequency of asymptomatic and symptomatic infections (with typical or atypical symptom manifestations) with influenza viruses (and other viruses)
3 years
Knowledge, attitudes, and practices (KAP) that predict vaccination hesitancy and refusal among healthcare personnel
3 years
Interventions
exposure to influenza vaccine
Eligibility Criteria
Healthcare personnel
You may qualify if:
- Be aged ≥18 years old;
- Work at the facility full-time (≥30 hours per week);
- Have routine direct hands-on or face-to-face contact with patients (within 1 meter) as part of a typical work shift, including, but not limited to, physicians, nurses, respiratory therapists, physical therapists, unit clerks, radiograph technicians, medical assistants, and transporters;
- Continuous membership in Clalit Health plan for at least 1 year prior to enrollment.
You may not qualify if:
- No routine direct patient contact;
- Works part-time;
- Already received current season's flu vaccine more than 48 hours before enrollment and, thus, cannot complete blood draw prior to full immune response to the vaccine;
- Not be a member of the Clalit Health System health plan.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Abt Associateslead
- Centers for Disease Control and Preventioncollaborator
- Clalit Research Institutecollaborator
Study Sites (2)
Soroka Medical Center
Beersheba, 85025, Israel
Rabin Medical Center
Petah Tikva, Israel
Related Publications (1)
Hirsch A, Katz MA, Laufer Peretz A, Greenberg D, Wendlandt R, Shemer Avni Y, Newes-Adeyi G, Gofer I, Leventer-Roberts M, Davidovitch N, Rosenthal A, Gur-Arie R, Hertz T, Glatman-Freedman A, Monto AS, Azziz-Baumgartner E, Ferdinands JM, Martin ET, Malosh RE, Neyra Quijandria JM, Levine M, Campbell W, Balicer R, Thompson MG; SHIRI workgroup. Study of Healthcare Personnel with Influenza and other Respiratory Viruses in Israel (SHIRI): study protocol. BMC Infect Dis. 2018 Nov 6;18(1):550. doi: 10.1186/s12879-018-3444-7.
PMID: 30400834DERIVED
Biospecimen
Blood specimens and respiratory specimens will be collected.
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mark Thompson, PhD
Centers for Disease Control and Prevention
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 27, 2016
First Posted
November 6, 2017
Study Start
September 28, 2016
Primary Completion
July 1, 2019
Study Completion
July 1, 2019
Last Updated
July 31, 2024
Record last verified: 2017-11
Data Sharing
- IPD Sharing
- Will not share